OXYCODONE 5/APAP 500 Drug Patent Profile
✉ Email this page to a colleague
When do Oxycodone 5/apap 500 patents expire, and when can generic versions of Oxycodone 5/apap 500 launch?
Oxycodone 5/apap 500 is a drug marketed by Bristol Myers Squibb and is included in one NDA.
The generic ingredient in OXYCODONE 5/APAP 500 is acetaminophen; oxycodone hydrochloride. There are sixty-six drug master file entries for this compound. Thirty-six suppliers are listed for this compound. Additional details are available on the acetaminophen; oxycodone hydrochloride profile page.
Summary for OXYCODONE 5/APAP 500
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 1 |
Clinical Trials: | 563 |
Patent Applications: | 8 |
Formulation / Manufacturing: | see details |
DailyMed Link: | OXYCODONE 5/APAP 500 at DailyMed |
Recent Clinical Trials for OXYCODONE 5/APAP 500
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Washington State University | Early Phase 1 |
National Center for Complementary and Integrative Health (NCCIH) | Early Phase 1 |
University of Miami | Phase 2 |
Anatomical Therapeutic Chemical (ATC) Classes for OXYCODONE 5/APAP 500
US Patents and Regulatory Information for OXYCODONE 5/APAP 500
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bristol Myers Squibb | OXYCODONE 5/APAP 500 | acetaminophen; oxycodone hydrochloride | TABLET;ORAL | 085911-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |